Clinical Trial Update: Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy [Phase 2]

View source ↗

Summary

Phase 2 study evaluating docetaxel and prednisolone with or without zoledronic acid and/or Strontium-89 in patients with prostate cancer that has metastasized t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Metastron (strontium-89 chloride)
• Prednisolone (Prednisolone)
• Taxotere (docetaxel)
• Zometa (Zoledronic acid)

Snippet

Sponsor: University Hospital Birmingham | Conditions: Metastatic Cancer, Prostate Cancer | Phase 2 | Status: COMPLETED